This site uses cookies to measure how you use the website so it can be updated and improved based on your needs and also uses cookies to help remember the notifications you’ve seen, like this one, so that we don’t show them to you again. If you could also tell us a little bit about yourself, this information will help us understand how we can support you better and make this site even easier for you to use and navigate.

This database contains 2 studies, archived under the term: "acetylcholinesterase inhibitor"

How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central acetylcholinesterase inhibitor, and propiverine, a peripheral muscarine receptor antagonist

Although urinary incontinence inevitably occurs in advanced stages of dementia of any etiology, urinary urgency or frequency, also called an overactive bladder (OAB), occurs more commonly in dementia with Lewy bodies (DLB) and vascular dementia than it does in Alzheimer’s disease (AD). Acetylcholinesterase (AChE) inhibitors for dementia and anticholinergics for OAB have been widely used, […]

Exploring sleep‐related outcomes in patients with mild to moderate Alzheimer’s disease initiating acetylcholinesterase inhibitor therapy: The Morpheus survey

Presents a study which aims to explore sleep related outcomes in patients with mild moderate Alzheimer’s disease (AD) initiating acetylcholinesterase inhibitor therapy. This study is a prospective, observational, longitudinal, multicentre survey evaluating sleep quality in AD patients initiating acetylcholinesterase inhibitor (AChEI) treatment. Data for this study were collected at AChEI initiation and after 3 to […]

Try searching our database by another keyword...

To make a new query of the database, please enter your search terms below: